Reserpine

Hypertensive disease

Treatment

1 FDA approval

20 Active Studies for Reserpine

What is Reserpine

Reserpine

The Generic name of this drug

Treatment Summary

Reserpine is a type of alkaloid found in two plants, Rauwolfia serpentina and R. vomitoria. It works by blocking the uptake of norepinephrine into storage vesicles, which leads to a decrease of catecholamines and serotonin in the body. It has been used to treat high blood pressure and certain mental health conditions, but its side effects limit its use in clinical settings.

Ser-Ap-Es

is the brand name

image of different drug pills on a surface

Reserpine Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Ser-Ap-Es

Reserpine

1960

8

Approved as Treatment by the FDA

Reserpine, also called Ser-Ap-Es, is approved by the FDA for 1 uses like Hypertensive disease .

Hypertensive disease

Used to treat High Blood Pressure (Hypertension) in combination with Polythiazide

Effectiveness

How Reserpine Affects Patients

Reserpine is a drug used to lower blood pressure by blocking substances (norepinephrine) that control the rate of your heart, the force of your heart's contractions, and the amount of resistance in your blood vessels. It does this by preventing these substances from being stored in nerve endings.

How Reserpine works in the body

Reserpine stops the body from storing neurotransmitters in presynaptic neurons. This prevents the neurotransmitters from being available to be used, and they are instead broken down by an enzyme called monoamine oxidase. This reduces the amount of catecholamines in the body.

When to interrupt dosage

The suggested quantity of Reserpine is contingent upon the diagnosed condition. The dosage fluctuates as per the delivery method outlined in the table beneath.

Condition

Dosage

Administration

Hypertensive disease

, 0.1 mg, 0.25 mg, 0.125 mg, 25.0 mg

Oral, Tablet, , Tablet - Oral, Tablet, coated - Oral, Tablet, coated

Warnings

There are 20 known major drug interactions with Reserpine.

Common Reserpine Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The serum concentration of Abemaciclib can be increased when it is combined with Reserpine.

Amifostine

Major

Reserpine may increase the hypotensive activities of Amifostine.

Amisulpride

Major

Reserpine may increase the antipsychotic activities of Amisulpride.

Astemizole

Major

The metabolism of Astemizole can be increased when combined with Reserpine.

Axitinib

Major

The serum concentration of Axitinib can be increased when it is combined with Reserpine.

Reserpine Toxicity & Overdose Risk

This drug has the potential to cause cancer in humans. It may also harm reproductive health. Tests have shown that when given orally to rats, the lethal dose is 420mg/kg, when given intravenously it is 15mg/kg, and when given to mice, it is 200mg/kg and 52mg/kg respectively. When given by injection to rabbits, the lethal dose is 7mg/kg.

image of a doctor in a lab doing drug, clinical research

Reserpine Novel Uses: Which Conditions Have a Clinical Trial Featuring Reserpine?

18 active trials are currently underway to assess the utility of Reserpine for the treatment of Hypertensive disease.

Condition

Clinical Trials

Trial Phases

Hypertensive disease

27 Actively Recruiting

Not Applicable, Phase 1, Phase 2, Phase 3

Reserpine Reviews: What are patients saying about Reserpine?

5

Patient Review

3/10/2012

Reserpine for High Blood Pressure

I've been using this medication for 30 years now and it's still working great with no side effects!

5

Patient Review

6/9/2010

Reserpine for Severe Mental Disorder with Loss of Personality & Reality

This treatment is amazing. I'm grateful for modern medicine.

4.3

Patient Review

6/25/2009

Reserpine for High Blood Pressure

image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about reserpine

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the drug reserpine used for?

"Reserpine is a medication used to lower blood pressure, treat psychiatric disorders, and tardive dyskinesia. It is available as the brand name Serpasil."

Answered by AI

Why reserpine is not used clinically?

"Reserpine was approved for use in the United States in 1955. However, it is currently not often used because it can cause central nervous system effects and there are many other antihypertensive medications that are more tolerated and more potent."

Answered by AI

What is reserpine mechanism of action?

"Reserpine irreversibly blocks the vesicular monoamine transporter-2 (VMAT-2), which is involved in adrenergic neurotransmission. This blockage prevents serotonin, norepinephrine, and dopamine from being taken up into presynaptic storage vesicles."

Answered by AI

Where is reserpine found?

"In the 1950s the Indian scientist K.C. Appa and his colleagues showed that reserpine, the principal alkaloid of the root, was the active ingredient in treating high blood pressure

Reserpine is a drug that comes from the roots of certain tropical plants in the Rauwolfia species. In the past, the powdered root of the Indian shrub Rauwolfia serpentina was used to treat snakebites, insomnia, and high blood pressure. In the 1950s, Indian scientist K.C. Appa and his colleagues discovered that reserpine, the main alkaloid in the root, was what was actually effective in treating high blood pressure."

Answered by AI

Clinical Trials for Reserpine

Image of Miles Square Health Center Chicago in Chicago, United States.

Food is Medicine for High Blood Pressure and Obesity

Any Age
All Sexes
Chicago, IL

The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?

Phase 2
Waitlist Available

Miles Square Health Center Chicago (+3 Sites)

Image of U Health in Miami, United States.

Cuffless PPG Monitor for High Blood Pressure

18+
All Sexes
Miami, FL

This study aims to validate the accuracy and reliability of blood pressure (BP) estimates obtained over 24 hours using a PPG-based chest-patch device compared to the gold standard ambulatory blood pressure monitoring (ABPM) method using an upper arm cuff-based oscillometric BP device, in both hypertensive and normotensive individuals referred by their provider to undergo a 24-hours ABPM for clinical indication. The Awake/Asleep test, which is the primary test recommended for automated wearable cuffless BP devices that are cuff-calibrated (based on the 2023 European Society of Hypertension (ESH) recommendations for the validation of cuffless blood pressure measuring devices), will be conducted in this study. The secondary aim of the study is to assess the feasibility and convenience of the PPG-based device.

Waitlist Available
Has No Placebo

U Health (+1 Sites)

Ziad Zoghby, M.D., M.B.A.

Biobeat Technologies Ltd.

Have you considered Reserpine clinical trials?

We made a collection of clinical trials featuring Reserpine, we think they might fit your search criteria.
Go to Trials
Image of Wayne Health Mobile Units in Detroit, United States.

Text Message Reminders for High Blood Pressure

18+
All Sexes
Detroit, MI

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early PreVEntion in the GREAT LakEs Region) Center (IRB# 100221MP2A), the purpose of which is to improve cardiometabolic health in two uniquely comparable cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center involves separate but related projects that aim to improve cardiometabolic health outcomes through better risk factor control for three chronic conditions that are of tremendous public health importance, (hypertension (HTN), heart failure, and coronary heart disease), all of which contribute significantly to premature death in Detroit and Cleveland. The present study is the prospective observational cohort component of ACHIEVE P1- EPI (Project 1) of the ACHIEVE GREATER Center and serves to characterize the population of patients with blood pressure (BP) levels above normal attending The Wayne Health Mobile Health Unit (MHU) events to better understand key factors (e.g., social determinants of health) that convey information about baseline BP levels and related clinical outcomes (e.g., follow-up clinic visits, BP control, and cardiovascular events).

Recruiting
Has No Placebo

Wayne Health Mobile Units

Steven J Korzeniewski, PhD

Have you considered Reserpine clinical trials?

We made a collection of clinical trials featuring Reserpine, we think they might fit your search criteria.
Go to Trials
Image of Northern Arizona University in Flagstaff, United States.

CardioCare Quest for High Blood Pressure

18+
All Sexes
Flagstaff, AZ

This project aims to address healthcare disparities among Navaho people diagnosed with hypertension or prehypertension through three main objectives. Firstly, it identifies and shares insights on healthcare access disparities affecting Navaho individuals experiencing nonadherence to hypertension treatment. Secondly, the proposal develops a telehealth solution based on factors identified as knowledge gaps caused by healthcare access disparities in hypertension management; we will use the factors to design a series of engaging minigames that can be incorporated into the larger CardioCare Quest. These minigames will be co-designed with end users and clinicians. Finally, the proposal conducts comprehensive qualitative and quantitative assessments of user experiences, perceptions, and challenges with CardioCare Quest.

Recruiting
Has No Placebo

Northern Arizona University (+1 Sites)

Tochukwu Ikwunne, PhD

Image of Tufts University in Boston, United States.

Food as Medicine for Cardiometabolic Health

18+
All Sexes
Boston, MA

Though the Mississippi Delta has a rich agricultural history and some of the nation's most fertile soil, residents have experienced the legacy of slavery and economic exploitation through food insecurity and poverty for generations. This project focuses on Bolivar, Washington, and Sunflower, contiguous counties in the Delta that are designated as health disparity populations. Over 65% of the 100,000 residents are Black/African American and \~30% live at or below the poverty level. Obesity rates are high and the rate of diabetes is almost double the national average. Tufts University received a grant from the National Institute of Minority Health and Health Disparities to develop, test, and evaluate a Food is Medicine program in Mississippi. The Delta Growing a Resilient, Enriching, Equitable, Nourishing food System (GREENS) Food is Medicine (FIM) Project, is a collaborative project in Bolivar, Washington, and Sunflower counties in Mississippi. The intervention involves regularly distributed fruit and vegetable produce boxes as well as nutrition education materials to the intervention group. The control group will receive produce boxes later, after they complete study activities. The project's primary goal is to improve health outcomes by creating a FIM intervention. The Delta GREENS FIM Project aims to become a model for promoting nutrition security and management of chronic conditions in varied communities nationwide.

Recruiting
Has No Placebo

Tufts University

Christina D Economos, PhD

Have you considered Reserpine clinical trials?

We made a collection of clinical trials featuring Reserpine, we think they might fit your search criteria.
Go to Trials